Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2008
10/01/2008EP1709161B1 Human therapeutic cells secreting nerve growth factor
10/01/2008EP1646364B1 Hfc solution formulations containing an anticholinergic
10/01/2008EP1528914B1 Antigenic compositions
10/01/2008EP1363600B1 Liquid formulations for the prevention and treatment of mucosal diseases and disorders
10/01/2008EP1328258B1 A controlled-release, parenterally administrable microparticle preparation
10/01/2008EP1251862B1 Ophthalmic compositions for treating ocular hypertension
10/01/2008EP1230855B1 Sustained-release preparation of aqueous dispersion type and process for producing the same
10/01/2008CN101277977A Cancerous disease modifying antibodies
10/01/2008CN101277722A Composition and method for prevention and treatment of type I diabetes
10/01/2008CN101277721A Orally disintegrating tablet
10/01/2008CN101277720A Method for preparation of pharmaceutical composition having improved disintegradability
10/01/2008CN101277715A Treatment of neurodegenerative disorders
10/01/2008CN101277709A A medical composition for treating wounds
10/01/2008CN101277699A Sustained-release preparation
10/01/2008CN101277680A Orodispersible tablets of bitter active principles
10/01/2008CN101277679A Pharmaceutical compositions stabilized in glassy particles
10/01/2008CN101277674A Stabilization of body-care and household products against degradation by UV radiation using merocyanine derivatives
10/01/2008CN101277612A Composition and method for use in cartilage affecting conditions
10/01/2008CN101275143A Nucleic acid encoding hyaluronan synthase and methods of use
10/01/2008CN101274118A Physiotherapy electrode plate clamping self-pasting medicine carrying membrane and manufacture method thereof
10/01/2008CN101274100A Method for preparing adriamycin-dipeptide complexes and applications
10/01/2008CN101274099A Method for preparing polymer matrix with transfer function
10/01/2008CN101274097A Atomizing grippe vaccine composition and preparation thereof
10/01/2008CN101274096A Stable Batroxobin medicament composition
10/01/2008CN101274094A Gubao tablets and technique for producing and preparing the same
10/01/2008CN101274079A Dogskin plaster and technique of preparing the same
10/01/2008CN101274039A Tea pigment sustained-release dropping pills and method of preparing the same
10/01/2008CN101274028A Liver health care composition and preparation thereof
10/01/2008CN101274008A Sustained-release dropping pill of Tripterygium glycosides and method of preparing the same
10/01/2008CN101273997A Formulations of zhenmupian and other medicines and method for preparing the same
10/01/2008CN101273993A Mometasone furoate solution type liquid preparation
10/01/2008CN101273992A Long-acting antibiotic agent for animals and method of preparing the same
10/01/2008CN101273985A Composition method of capsule for improving female climacteric syndrome and preparing technique
10/01/2008CN101273977A Preparation technique of tryptanthrin preparations and uses thereof
10/01/2008CN101273976A Sustained-release dropping pills of Troxerutin and method for preparing the same
10/01/2008CN101273975A Sustained-release dropping pills of amoxicillin and ambroxol hydrochloride and method of preparing the same
10/01/2008CN101273974A Sustained-release dropping pill of azithromycin and method of preparing the same
10/01/2008CN101273972A Method for preparing magnetic adriamycin poly-alkyl-alfa-cyanoacrylate nanoparticles
10/01/2008CN101273971A Ethosomes preparation of antimycotics pharmaceutical and method for preparing the same
10/01/2008CN101273970A Microemulsion type preparation of glucocorticoid medicine for nasal cavity
10/01/2008CN101273969A Compound anticancer sustained-release agent containing Clofarabine
10/01/2008CN101273967A Anticancer sustained-release injection containing neovascularization inhibitor
10/01/2008CN101273966A Temperature controlled sustained-release injection comprising alkyl agent and method for preparing the same
10/01/2008CN101273965A Temperature controlled sustained-release injection containing anti-cancer medicine
10/01/2008CN101273964A Temperature controlled sustained-release injection containing platinum compound
10/01/2008CN101273963A Temperature controlled sustained-release injection containing steroids anti-cancer drugs
10/01/2008CN101273962A Temperature controlled sustained-release injection comprising alkyl agent and method for preparing the same
10/01/2008CN101273961A Glucose-sensitive hydrogels
10/01/2008CN100422268C Temperature sensing instant type gel system
10/01/2008CN100422197C Cyclic maltosyl maltose, cyclic maltosyl maltose synthase, method of producing the same and use thereof
10/01/2008CN100422186C Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
10/01/2008CN100421732C Plaster for the treatment of dysfunctions and disorders of nails
10/01/2008CN100421726C Nano compound eye-drop containing piptide-like medicine and preparing method
10/01/2008CN100421666C Epristeride slow release preparation
10/01/2008CN100421655C Pharmaceutical composition for stabilizing ambroxol hydrochloride granula
10/01/2008CN100421652C Pharmaceutical compsns. of conjugated estrogens and methods for their use
10/01/2008CN100421649C Transnasal microemulsions containing diazepam
10/01/2008CN100421648C Hydrocortisone clyster agent and method for preparing the same
10/01/2008CA2654894A1 Csf3r polypeptides and uses thereof
09/2008
09/30/2008US7430476 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity
09/30/2008US7429619 Polyacrylic film forming compositions
09/30/2008US7429564 Orally administering insulin and delivery agent 4-[(4-chloro, 2-hydroxybenzoyl)amino]butanoic acid that facilitates the absorption of insulin from the gastrointestinal tract; diabetes mellitus; bioavailability comparable to injection; treating diabetes without the drawbacks of systemic hyperglycemia
09/30/2008US7429563 Sequences of myeloperoxidase (MPO) that serve as albumin docking proteins (ADPs); e.g. sequence ELKSLNPRWDGE; conjugates with other drugs or biodrugs such as insulin to improve uptake via transcytosis
09/30/2008US7429562 Form a clear microemulsion upon contact with an aqueous medium; preconcentrates; reduced toxicity but high bioavailability; contain cyclosporin A analog ISATx247 (Voclosporin), tocopheryl polyethylene glycol 1000 succinate (Vitamin E TPGS), medium chain triglyceride (MCT) oil, emulsifier, and ethanol
09/30/2008US7429559 Controlled release composition and method of producing the same
09/30/2008US7429467 Solution comprising surfactant, hydrophobic phase and hydrophilic phase comprising plurality of microcapsules containing functional in vitro eukaryotic expression system for transfer of heterologous into cells
09/30/2008US7429458 Binding preferential protein or peptide in sample; obtain sample containing peptides or proteins, incubate with elastomeric compound, heat, separate and recover bound bioplymers
09/30/2008US7429394 Core comprising a potassium binding polymer, shell component comprising a crosslinked amine functional polymer alkylated with hydrophobic agent(s); treatment of phosphate imbalance disorders, hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, chronic renal insufficiency
09/30/2008US7429390 Alcohol free, liquid ranitidine formulations for oral administration; high concentration of the saccharides that help mask the taste of ranitidine
09/30/2008US7429382 Antibodies that bind cell-associated CA 125/O772P and methods of use thereof
09/30/2008US7429377 Therapeutic composition containing a plurality of immobilized proteases
09/30/2008CA2626625A1 Intranasal drug delivery system
09/30/2008CA2453646C 5-cnac as oral delivery agent for parathyroid hormone fragments
09/30/2008CA2450772C Composition for epigallocatechin gallate
09/30/2008CA2405716C Chemically modified novel erythropoietin stimulating protein compositions and methods
09/30/2008CA2382564C Cyclodextrin containing pressure sensitive adhesives
09/30/2008CA2371031C Compositions for treatment of disorders of the oesophagus
09/30/2008CA2313642C Pharmaceutical hydrogel formulations, drug delivery devices and methods
09/30/2008CA2305704C Peptide/lipid complex formation by co-lyophilization
09/30/2008CA2222811C Stabilized solid dispersions of misoprostol
09/30/2008CA2221096C Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
09/30/2008CA2190509C Hepatocyte-selective oil-in-water emulsion
09/30/2008CA2082382C Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
09/25/2008WO2008116158A1 Supramolecular complexes as photocatalysts for reduction of substrates
09/25/2008WO2008116111A2 Growth factor mediated cosmeceuticals and use thereof to enhance skin quality
09/25/2008WO2008115805A2 Cobalamin taxane bioconjugates
09/25/2008WO2008115061A2 Dual targeting system
09/25/2008WO2008114861A1 Alcohol-containing quinolone pharmaceutical composition
09/25/2008WO2008114859A1 Pharmaceutical composition containing pyrazole derivative
09/25/2008WO2008114787A1 Antiviral agent
09/25/2008WO2008114679A1 Bone metabolism ameliorating agent
09/25/2008WO2008114516A1 Liposome and immunostimulating composition comprising the same
09/25/2008WO2008114513A1 Prophylactic and/or therapeutic agent for cardiac infarction
09/25/2008WO2008114021A1 Method for preserving viral particles
09/25/2008WO2008113601A1 Glp-1 fusion peptides conjugated to polymer(s), their production and use
09/25/2008WO2008113421A1 New pharmaceutical compositions for lipolysis and method for the production thereof
09/25/2008WO2008113185A1 Antagonists of ligands and uses thereof
09/25/2008WO2008113177A1 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
09/25/2008WO2008113146A1 Pharmaceutical composition with antifungal activity containing cymbopogon nardus, its process, and use
09/25/2008WO2008113144A1 Nanoparticulated anesthetic composition for topic use
1 ... 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 ... 1712